Showing results (451-460 of 655) with videos related to

Sort By:
Pageof 66
Journal of Clinical Pharmacy and Therapeutics|September 16, 2011
High dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failureM E Gomes, S El Messaoudi, J W M Lenders, et al.
Inflammation|February 1, 2020
Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLDAndreea-Manuela Mirea, Rinke Stienstra, Thirumala-Devi Kanneganti, et al.
Diabetes, Obesity & Metabolism|July 11, 2025
Association between recent real-life exposure to hypoglycaemia and cognitive function during hypoglycaemia in people with type 1 diabetes: Findings from the Hypo-RESOLVE clamp studyCecilie H Svensson, Therese W Fabricius, Clementine Verhulst, et al.
European Journal of Endocrinology|October 7, 2016
Determinants of hypomagnesemia in patients with type 2 diabetes mellitusSteef Kurstjens, Jeroen H F de Baaij, Hacene Bouras, et al.
Gut|December 3, 2005
Functional dyspepsia, delayed gastric emptying, and impaired quality of lifeN J Talley, G R Locke, B D Lahr, et al.
Neurogastroenterology and Motility|May 3, 2016
Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI studyA Rubio, S Pellissier, L Van Oudenhove, et al.
Clinical Immunology (Orlando, Fla.)|June 16, 2015
One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitusEdwin J P van Asseldonk, Pleun C M van Poppel, Dov B Ballak, et al.
Diabetes Care|February 3, 2011
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trialTim Heise, Cees J Tack, Robert Cuddihy, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2007
New algorithm for the treatment of gastro-oesophageal reflux diseaseG N Tytgat, K McColl, J Tack, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 5, 2002
Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patientsE J Abbink, P Pickkers, A Jansen van Rosendaal, et al.
Pageof 66